Artificial Vital Organs And Medical Bionics Market Growth & Trends
The global artificial vital organs and medical bionics market size is expected to reach USD 70.1 billion by 2030, registering a CAGR of 9.3% from 2024 to 2030. Key growth drivers identified in the artificial vital organs market include increasing base of geriatric population suffering from chronic diseases such as cardiovascular and respiratory diseases leading to organ failures or damage.Furthermore, the increasing number of patients suffering from physical disabilities such as loss of limbs and arms owing to congenital factors, accidents, serving in armed forces and industrial accidents is likely to positively reinforce medical bionics market growth over the forecast period.
The proliferation of universal health coverage schemes launched by various governments and increasing public and private reimbursement policy coverage are major trends expected to boost the usage rates of artificial vital organs and medical bionics in the next seven years.
The artificial vital organs market includes products such as artificial heart, pancreas, kidneys, and lungs. These are used for organ transplantation in patients suffering with organ damages or complete organ failures.
In 2014, artificial kidney market accounted for the largest market share of over 60% owing to increasing prevalence of high blood sugar, hypertension, post-surgery infections, glomerular diseases, injury or burns, HIV, and other risk factors.
Artificial liver is expected to be the fastest growing product segment growing at a lucrative rate over the forecast period of seven years. Key factors attributing to its rapid growth include increasing prevalence of chronic lung diseases such as COPD and disadvantages of using mechanical ventilators.
The medical bionics segment includes products such as brain, ear, vision bionics, exoskeleton, and bionic limbs. In 2014, brain bionics held the largest market share of nearly 41% due to the continually increasing number of patients suffering from neurological conditions. Furthermore, non-invasive nature of spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators are key factors positively impacting market growth in the next seven years. Exoskeletons are likely to witness a rapid rise in demand owing to its wide applications in rescue, emergency response, home healthcare, and patient rehabilitation.
Artificial Vital Organs And Medical Bionics Market Report Highlights
- Brain bionics dominated the artificial vital organs and medical bionics market with a revenue share of 34.9% in 2023. Increased prevalence of neurological conditions such as Parkinson’s disease, depression, and epilepsy are driving market growth.
- The heart segment dominated the market with a revenue share of 57.3% in 2023. This increase is happening due to an increase in the incidence of chronic diseases, scarcity of hearts for transplant, and advancement of the operations and potent effective drugs and treatment.
- North America artificial vital organs and medical bionics market dominated the global artificial vital organs and medical bionics market with a revenue share of 44.6% in 2023.
- Asia Pacific artificial vital organs and medical bionics market is expected to the fastest growth in the forecast period with a CAGR of 11.1%. Due to rising disposable income, elevated healthcare infrastructure, and awareness the marketplace is displaying growth within the forecast period.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Artificial Vital Organs and Medical Bionics Market Variables, Trends, & Scope
Chapter 4. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Estimates & Trend Analysis
Chapter 5. Artificial Vital Organs and Medical Bionics Market: Bionics Estimates & Trend Analysis
Chapter 6. Artificial Vital Organs and Medical Bionics Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Medtronic, Inc.
- LifeNet Health
- Terumo Corporation
- Ekso Bionics Holdings, Inc.
- Nano Retina Ltd.
- Edwards Lifesciences Corporation
- InnoScot Health Ltd.
- Ottobock SE & Co. KGaA
- Orthofix Medical Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | August 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 37.6 Billion |
Forecasted Market Value ( USD | $ 70.1 Billion |
Compound Annual Growth Rate | 9.3% |
Regions Covered | Global |
No. of Companies Mentioned | 9 |